Delivery Order SPE2DB20D2104-SPE2DB23FR97Z
- Not listed
- This federal contract award, valued at $1,688.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4559754687 TOVIAZ ER 8 MG TABLET 30S, with a completion date of January 30, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract, valued at $2,724.21, is for the delivery of TOVIAZ ER 8 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance extending through May 28, 2025. This award is not associated with a set-aside designation,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,313.70, is for the supply of the medication TOVIAZ ER 8 MG TABLET 30S. The contract has a firm-fixed price pricing type and runs through May 31, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,014.82, is for the supply of TOVIAZ ER 8 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 31, 2024 and is a firm fixed-price, delivery order contract. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,677.60 order is for the supply of TOVIAZ ER 4 MG TABLET 30S, a pharmaceutical product. The delivery order has a completion date of February 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA, with a potential value of $999,999,999.00 and...
- This federal contract award to Amerisourcebergen Drug Corp, valued at $1,461.42, is for the delivery of the pharmaceutical product TOVIAZ ER 8 MG TABLET 30S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, is the prime contractor for this delivery order contract. The contract is a firm fixed-price arrangement with a completion date of July 11, 2024....
- This federal contract award, with ID SPE2DB22D1202|SPE2DB25FUSJ2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,262.25 firm-fixed-price delivery order is for the provision of TOVIAZ ER 8 MG TABLET 30S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TOVIAZ ER 4 MG TABLET 30S. The $1,602.90 firm fixed-price contract has a completion date of June 23, 2023 and is not designated with a set-aside requirement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a wide range...
- This federal contract award, with the ID SPE2DB24D2011|SPE2DB24FBPPU, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,559.96, is a Firm Fixed Price Delivery Order for the supply of TOVIAZ ER 4 MG TABLET 30S. It has an ultimate completion date of May 1, 2024. The contract is not designated with any set-aside requirements, indicating it was awarded through full and open competition....
- This federal contract award, with an ID of SPE2DB22D1106|SPE2DB24FEXD6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,706.11 firm-fixed-price delivery order is for the supply of 4564910533 TOVIAZ ER 4 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of June 17, 2024 and was awarded on June 14, 2024. AmerisourceBergen, a for-profit organization,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FR97ZDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,778.94 firm-fixed-price delivery order is for the supply of TOVIAZ ER 8 MG TABLET 30S, a prescription medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This delivery order has a performance period through January 30, 2023 and is one of many awarded to Amerisourcebergen by federal agencies such as the Department of Justice Federal Bureau of Investigation to deliver essential medical commodities, including specialty drugs, generic medications, vaccines, and medical equipment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 1/27/23 |